Author: Sarah Buhr

One Medical raises $350 million from Carlyle Group to help double up offices and offerings

One Medical has confirmed to TechCrunch it has closed on funding from the Carlyle Group for a new cash infusion worth $350 million. This announcement follows an earlier report this week One Medical was seeking to close a $200 million deal, on top of a possible $100 million in stock for the financing firm. However, we have since learned the deal is a tad higher, including $220 toward the primary equity investment and another $130 million in a secondary investment. CEO Amir Rubin tells TechCrunch the new funds will go toward a serious expansion for the company, including doubling...

Read More

One Medical may be in talks to raise more than $200 million

One Medical, the company hoping to disrupt the doctor’s office with concierge services, virtual visits and same-day appointments, is rumored to be in late-stage talks with the Carlyle Group for $200 million in funding, according to CNBC. The firm is also looking to buy an additional $100 million worth of shares from existing investors, according to the report. We’ve reached out to the Carlyle Group and One Medical for more information. One Medical has so far raised over $180 million, including from Alphabet’s venture arm GV and Benchmark Capital, to bring its idea of accessible healthcare to areas covering...

Read More

The SEC has charged Mike Rothenberg for fraud

Mike Rothenberg, infamous Silicon Valley venture capitalist and founder of Rothenberg Ventures, has been formally charged by the Securities and Exchange Commission for overcharging investors to fund personal projects. Rothenberg had been under investigation by the SEC for quite some time. The SEC now alleges in a statement the investor and his firm had misappropriated up to $7 million dollars for personal enjoyment, meanwhile claiming the funds were from his own coffers to pay for lavish parties, hotels and sporting...

Read More

Safety and inspection bot startup Gecko Robotics adds $7 million to the coffers

Gecko Robotics aims to save human lives at our nation’s power plants with its wall-climbing robots. To continue doing so, the startup tells TechCrunch it has just secured $7 million from a cadre of high-profile sources including Founders Fund, Mark Cuban, The Westly Group, Justin Kan and Y Combinator. We first reported on the Pittsburgh-based company when co-founder Jake Loosararian came to the TechCrunch TV studios to show off his device for the camera. Back then, Gecko was in the YC Spring 2016 cohort, working with several U.S. power plants and headed toward profitability, according to Loosararian.  You can see the original interview below: The type of robots Gecko makes are an important part of ensuring safety in industrial and power plant facilities as they are able to go ahead of humans to check for potential hazards. The robots can climb tanks, boilers, pipelines and other industrial equipment using proprietary magnetic adhesion, ultra-sonics, lasers and a variety of sensors to inspect structural integrity, according to a company release. While not cheap — the robots run anywhere from $50,000 to $100,000 — they are also obviously a minuscule cost compared to human life. Gecko robot scaling the wall for a safety inspection at a power plant. Loosararian also mentioned his technology was faster and more accurate than what is out there at the moment by using machine learning “to solve some of the most...

Read More

Cytera Cellworks aims to bring cell culture automation to your dinner plate

Cytera Cellworks hopes to revolutionize the so-called ‘clean meat’ industry through the automation of cell cultures — and that could mean one day, if all goes to plan, the company’s products could be in every grocery store in America. Cytera is a ways off from that happening, though. Founded in 2017 by two college students in the U.K., Ignacio Willats and Ali Afshar, Cytera uses robotic automation to configure cell cultures used in things like growing turkey meat from a petri dish or testing stem cells. The two founders — Willats, the events and startups guy and Afshar the scientist,...

Read More

The FDA OK’d an app as a form of birth control

Don’t want to get pregnant? There’s a Food and Drug Administration approved app for that. The FDA has just given the go ahead for Swedish app Natural Cycles to market itself as a form of birth control in the U.S. Natural Cycles was already in use as a way to prevent pregnancy in certain European countries. However, this is the first time a so-called ‘digital contraceptive’ has been approved in America. The app works using an algorithm based on data given by women using the app such as daily body temperature and monthly menstrual cycles. It then calculates the...

Read More

The SEC wants Tesla to explain Elon’s 420 tweet

Elon Musk, billionaire founder of Tesla, startled the Twittersphere yesterday by announcing he wanted to take the company private at the price of $420 per share. The tweet sent the stock soaring up 11 percent, causing a halt in trade for a portion of the day. Now, the Securities and Exchange Commission is looking into the matter. Am considering taking Tesla private at $420. Funding secured. — Elon Musk (@elonmusk) August 7, 2018 Wall Street Journal sources say the SEC has since made inquiries to Tesla to find out whether Musk’s tweet was truthful and why he chose to announce...

Read More

Otto co-founder Lior Ron is back at Uber

Lior Ron, the co-founder of the controversial self-driving technology company Otto, is returning to Uber to head up it’s trucking logistics company Uber Freight, TechCrunch has confirmed. Both Ron and his co-founder and ex-Googler Anthony Levandowski came into Uber after the announcement of the acquisition of Otto in August of 2016. However, Levandowski was fired from Uber after pleading the Fifth Amendment to his accused involvement in stealing Google’s self-driving car trade secrets for use in Otto’s technology. Ron exited Uber a month after the company settled with Google parent company Alphabet for $245 million over the dispute. Now, after...

Read More

Right Now in Politics and Business